Neuralink

Neuralink is a neurotechnology company developing ultra-high-bandwidth brain-machine interfaces, including their flagship N1 Implant (branded "Telepathy"), which is surgically implanted to enable people with paralysis and severe neurological conditions to control computers using their thoughts. The company is currently conducting FDA Breakthrough Device-designated human clinical trials and has implanted devices in 21 participants as of early 2026.